North China Pharmaceutical Company.Ltd (SHA:600812)
China · Delayed Price · Currency is CNY 5.12
+0.32 (6.67%)
Sep 10, 2026, 2:10 PM CST
SHA:600812 Revenue
North China Pharmaceutical Company.Ltd had revenue of 2.07B CNY in the quarter ending June 30, 2026, a decrease of -23.49%. This brings the company's revenue in the last twelve months to 8.19B, down -17.42% year-over-year. In the year 2025, North China Pharmaceutical Company.Ltd had annual revenue of 9.24B, down -6.36%.
Revenue (ttm)
8.19B
Revenue Growth
-17.42%
P/S Ratio
1.01
Revenue / Employee
820.92K
Employees
9,972
Market Cap
8.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.24B | -627.92M | -6.36% |
| Dec 31, 2024 | 9.87B | -250.63M | -2.48% |
| Dec 31, 2023 | 10.12B | -379.75M | -3.62% |
| Dec 31, 2022 | 10.50B | 115.37M | 1.11% |
| Dec 31, 2021 | 10.38B | -1.11B | -9.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.